Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Researcher (R3) Country Morocco Application Deadline 19 Sep 2025 - 00:00 (UTC) Type of Contract Permanent Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
experiments, including: Massively parallel reporter assays (MPRAs) Protein deep mutational scanning (DMS) assays CRISPR interference (CRISPRi) screens Genomic base-editing screens These experiments will be
-
) performing an experimental validation programme. The project is an interdisciplinary collaboration of researchers at the University of Bristol and researchers at the University of Lille, France, and the
-
experimental apparatus for model validation and (2) performing an experimental validation programme. The project is an interdisciplinary collaboration of researchers at the University of Bristol and researchers
-
the Strategic Plan 2022–2026 : Towards the University of the Future. As Deputy Vice-Chancellor (Research), you will be responsible for driving ECU’s research excellence, innovation, and enterprise agenda
-
and/or Matlab, parallel programming Experience in international collaboration Fluent in English (spoken and written) Demonstrated ability to publish in international journals and present at conferences
-
/neuropixel probes and electrical microstimulation to study attention and decision making networks in a behaving animal model together with parallel studies in humans. The project is part of a NIMH Silvio O
-
, excursions) Global geo-/paleomagnetic field modelling expertise is advantageous Strong programming skills, preferably in Fortran, Python and/or Matlab, parallel programming Experience in international
-
results. Machine Learning skills to automise comparison process. Unbiased approach to different theoretical models. Experience in HPC system usage and parallel/distributed computing. Knowledge in GPU-based
-
platform enables us to test hundreds of different conditions in parallel and assess their impacts on human immune responses, such as antibody production. We routinely work with industry partners to exploit